Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
COVID-19 BNT162b2 mRNA vaccine for patients with type 2 diabetes mellitus — Stavroula Α. Paschou (2022) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
COVID-19 BNT162b2 mRNA vaccine for patients with type 2 diabetes mellitus
Shared by
Meletios A Dimopoulos
COVID-19 BNT162b2 mRNA vaccine for patients with type 2 diabetes mellitus
Letter
2022
en
Authors
+12 more
SP
Stavroula Α. Paschou
VK
Vangelis Karalis
ΘΨ
Θεοδώρα Ψαλτοπούλου
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2022
Patients with type 2 diabetes mellitus present similar immunological response to COVID-19 BNT162b2 mRNA vaccine to healthy subjects: a prospective cohort study
Stavroula Α. Paschou
,
Vangelis Karalis
,
Θεοδώρα Ψαλτοπούλου
,
Ioanna Charitaki
,
Aimilia D. Sklirou
,
Vassiliki A. Iconomidou
,
Vasiliki Vasileiou
,
Georgia Kassi
,
Andromachi Vryonidou
,
Alexander Kokkinos
,
Nikolaοs Tentolouris
,
Erifili Hatziaggelaki
,
Ioannis P. Trougakos
,
Evangelos Terpos
,
Meletios A Dimopoulos
Article
2021
Cellular Immune Responses to BNT162b2 mRNA COVID-19 Vaccine in Patients with Chronic Lymphocytic Leukemia
Gilad Itchaki
,
Lior Rokach
,
Ohad Benjamini
,
Osnat Bairey
,
Adi D. Sabag
,
Helly Vernitsky
,
Hagai Cohen
,
Shahar Rotem
,
Uri Elia
,
Pia Raanani
,
Erez Bar‐Haim
,
Tamar Tadmor
Blood
Letter
2021
Why two doses of the BNT162b2 mRNA COVID-19 vaccine? A different strategy to speed up the vaccination process: single-dose of the BNT162b2 mRNA COVID-19 and other vaccines
Carlo La Vecchia
,
Stefano Centanni
,
Alberto Giovanni Gerli
Article
2022
Patients with autoimmune thyroiditis present similar immunological response to COVID-19 BNT162b2 mRNA vaccine with healthy subjects, but vaccination may affect thyroid function
Stavroula Α. Paschou
,
Vangelis Karalis
,
Θεοδώρα Ψαλτοπούλου
,
Vasiliki Vasileiou
,
Ioanna Charitaki
,
Tina Bagratuni
,
Vassiliki Ktena
,
Fotini Papandroulaki
,
Sentiljana Gumeni
,
Georgia Kassi
,
Ioannis P. Trougakos
,
Evangelos Terpos
,
Meletios A Dimopoulos
Article
2021
Myeloma patients with COVID‐19 have superior antibody responses compared to patients fully vaccinated with the BNT162b2 vaccine
Maria Gavriatopoulou
,
Evangelos Terpos
,
Panagiotis Malandrakis
,
Ioannis Ntanasis‐Stathopoulos
,
Αlexandros Briasoulis
,
Sentiljana Gumeni
,
Despina Fotiou
,
Eleni‐Dimitra Papanagnou
,
Magdalini Migkou
,
Foteini Theodorakakou
,
Evangelos Eleutherakis‐Papaiakovou
,
Nikolaos Kanellias
,
Ioannis P. Trougakos
,
Efstathios Kastritis
,
Meletios A Dimopoulos
Discussion(0)
No comments yet. Be the first to comment.